Bladder cancer: total antioxidant capacity and pharmacotherapy with vitamin-E.
Hamid MazdakZahra Tolou GhamariMehdi GholampourPublished in: International urology and nephrology (2020)
By reference to the significant difference between T-AOC in patients and healthy controls, our results strongly suggest a low level of T-AOC in patients with BC. The obtained changes in T-AOC before and after management with vitamin E recommended additional consideration associates with different stages and grade of tumor in patients with BC.